Breaking News
Koppers Holdings Forecasts Strong Financial Performance for 2024
Koppers Holdings is gearing up for a prosperous year ahead in 2024. The company is expecting to achieve impressive financial...
Global Partners LP Positioned for Strong Growth in 2024
Eric Slifka, President and CEO of Global Partners, announced that the company is starting 2024 with a strong financial position,...
Wedbush Analyst Reiterates Confidence in Kura Oncology with Outperform Rating and 37 Price Target
Wedbush analyst Robert Driscoll has once again expressed his confidence in Kura Oncology (NASDAQ: KURA), giving it an "Outperform" rating...
Wedbush Analyst Maintains Neutral Rating on Regenxbio with 21 Price Target
Wedbush analyst Andreas Argyrides has once again assessed Regenxbio (NASDAQ:RGNX) with a Neutral rating and upholds a $21 price target....
Shift4 Named Exclusive PointofSale Systems Partner of the New York Yankees
On February 28, 2024, Shift4 was announced as the exclusive Point-of-Sale Systems Partner of the New York Yankees, revolutionizing the...
Revolutionizing Healthcare Accessibility with the MGMini A Collaboration Between KORE and Medical Guardian
KORE and Medical Guardian have joined forces to introduce the groundbreaking MGMini, the first eSIM-powered medical alert device designed to...
Crinetics Pharmaceuticals Raises 350 Million in Oversubscribed Private Placement
Crinetics Pharmaceuticals has recently made headlines with their successful private placement of 8,333,334 shares of common stock at $42.00 per...
Novavax Reports Mixed Financial Results for Fourth Quarter 2022
On February 28, 2024, Novavax (NASDAQ: NVAX) released its fourth-quarter financial results, revealing a loss of $(1.44) per share. This...
vTv Therapeutics Secures 51 Million Private Placement for Advancing Type 1 Diabetes Therapies
vTv Therapeutics made headlines on February 28, 2024, with the announcement of a significant $51 million private placement from prominent...
Developing a Promising Therapeutic Option for ObesityRelated Inflammation Inflammasome ASC Inhibitor IC 100
Obesity is a prevalent global issue, affecting millions of individuals worldwide. It is characterized by chronic inflammation, which can lead...
Popular News
-
SunHydrogen Set for European Debut with Groundbreaking Technology
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Trade Desk Shares Face Mounting Pressure as Tariff Warnings Materialize
-
Kraft Heinz Stock: A Contradiction in Market Sentiment
-
Synopsys Shares Plummet Amid Fraud Allegations and Disappointing Earnings
